Notice of NINR's Participation on PA-17-182 "Innovations in HIV Testing, Adherence, and Retention to Optimize HIV Care Continuum Outcomes (R01)"

Notice Number: NOT-NR-17-022

Key Dates
Release Date: July 10, 2017

Related Announcements
PA-17-182

Issued by
National Institute of Nursing Research (NINR)

Purpose

The purpose of this Notice is to inform potential applicants that the National Institute of Nursing Research (NINR) is participating in PA-17-182, " Innovations in HIV Testing, Adherence, and Retention to Optimize HIV Care Continuum Outcomes (R01)"

The following additions have been made to reflect NINR's participation in this FOA:

Part 1. Overview Information

Components of Participating Organizations

National Institute of Nursing Research (NINR)

Catalog of Federal Domestic Assistance (CFDA) Number(s) 

93.361

Part 2. Section I. Funding Opportunity Description

National Institute of Nursing Research (NINR)

NINR’s participation in this FOA is limited to HIV/AIDS-related research that addresses the Office of AIDS Research Priority to “improve prevention or treatment of HIV-associated comorbidities and co-infections.”

Part 2. Section VII. Agency Contacts

The following contact person has been added:

Scientific/Research Contact(s)

Rebecca Henry, PhD, BSN, RN
National Institute of Nursing Research (NINR)
Telephone: 301-594-5976
Email: Rebecca.Henry@nih.gov

Financial/Grants Management Contact(s)
Oster, Kelli
National Institute of Nursing Research (NINR)
Telephone: 301-594-2177
Email: osterk@mail.nih.gov

All other aspects of this FOA remain unchanged.

Inquiries

Please direct all inquiries to:

Rebecca Henry, PhD, BSN, RN
National Institute of Nursing Research (NINR)
Telephone: 301-594-5976
Email: Rebecca.Henry@nih.gov